Junevity founder explains how developments in si

Startup leverages cultivated muscle tissue gener

Company demonstrates treatment with intravenous

Professionals across insurance, pensions and res

Plasma biomarker measuring tau tangles aids diag

Company’s ‘precise and reversible’ RNA-edi

Company’s ‘precise and reversible’ RNA-edi

Rejuve Longevity users can monetize their health

Company to expand multi-ancestry biobank to supp

Survey of 82 clinics highlights technology uptak

Startup aims for clinical trial of lead candidat

Eighteen-month expedition sets out to examine lo

ThirdLaw Molecular is developing a new class of

Trial aims to demonstrate capacity to extend hea

Landmark conference concludes with call for unif

ARMMs technology expands scope of potential epig

Research highlights role of C15:0 in cellular re

Company says senolytic therapeutic delivers ‘r

Startup boasts pipeline of candidates targeting

Participants saw gains in strength, immune funct

Human Longevity pledges $1 million for advanced

TruDiagnostic Founder Ryan Smith on personalized

Epigenetic reprogramming startup identifies mult

New RNAi therapeutic offers a novel mechanism to

Startup aims for clinical trials of microglia-ta

Study suggests anti-amyloid treatment may halve

Elevant’s best-selling biohacking product prov

Company to initiate clinical study of gene-silen

Sens.

Portuguese defender invests more than €1 milli

Longevity startup offers AI-powered blood biomar

New research finds that endothelial TDP-43 loss

Progress in spinal cord injury lays the foundati

London is the setting for the next edition of a

Immorta Bio is developing autologous stem cell a

New COO Michael Ringel says company is confident

Company gears up for pivotal trials of AI-develo

New research highlights the dominant role of env

Company’s platform integrates labs and more th

Regenerative medicine startup aims to regenerate

Therapeutic interventions that stop or reverse a

PET tracer derived from an ALS treatment provide

Company files patent for treatment of chemothera

BSRA Chair David Weinkove on how a league table

Biotech gains DSMB approval to escalate dosing a

Research also identifies key methylation sites,

Berlin’s YEARS clinic analyzes patient health

Pfizer and Lilly join investors in biotech seeki

ChromaDex CEO Rob Fried on the importance of NAD

Public offering supports trials of gene therapie